Israel Schreiber

Israel Schreiber is a seasoned professional with over two decades of managerial experience in the medical device industry, spanning across Israel and the United States.

His expertise in the medical field includes Imaging, Cardiology, and Sleep Medicine, demonstrating a deep understanding of various aspects within the industry.

Israel has held senior management and executive roles, even serving as a CEO in both Israel and the US, showcasing his leadership and strategic abilities.

He has a proven track record in business development, having been involved from the early stages to establishing multi-million international Sales and Marketing, R&D, and Operations departments in organizations.

Israel Schreiber is known for his adeptness in forming strategic partnerships and collaborations with renowned medical institutions and pharmaceutical companies globally, highlighting his proficiency in building strong networks.

His experiences also include overseeing financing rounds, including the successful completion of an Initial Public Offering (IPO), indicating his financial acumen and capability in navigating complex processes.

Throughout his career, Israel has worked in a diverse range of organizations, from high-tech startups with steady growth trajectories to large public companies with extensive worldwide sales networks, underscoring his adaptability and versatility in different organizational structures and scales.

He has been associated with prominent entities such as HealthWatch Ltd., where he currently holds the position of CEO, and as a former Board Advisor at CardioKol, reflecting his engagement with innovative and impactful ventures in the industry.